Featured
Malaria vaccine: 77% efficacy
EDCTP-funded phase II clinical trial in Burkina Faso demonstrates that malaria vaccine candidate R21/Matrix-M is safe, immunogenic and has an efficacy of 77%.
10th EDCTP Forum - Call for abstracts
The 10th EDCTP Forum 'Equity in Research for Health' will take place from 17-21 October 2021.
The call for abstracts is now open! Deadline: 28 June 2021.
EDCTP Update April 2021
EDCTP’s monthly electronic newsletter | project news, events, funding and resources
Projects
Access our online projects database and guidance information to manage EDCTP2 grants.
Achievements
See our achievements in bringing together research from Europe and Africa and developing research capacity in sub-Saharan Africa.
News
15 June 2021
IAVI led consortium receives EDCTP and CEPI funding for a large-scale clinical trial of Lassa fever vaccine candidate
04 May 2021
New support tools for TB vaccine R&D published
30 April 2021
Call for abstracts for the Tenth EDCTP Forum
Latest Tweets
The Equitable Partnerships project “From Principles to Practice” is a partnership between @UKCDR & ESSENCE
This su… https://t.co/hNtubk3uR9See the post
9 hours ago
⏰6 days left to submit your abstract
For more info: https://t.co/yow3FrT0QE
#Abstract #edctpforum #equity… https://t.co/9GaZiLWHJcSee the post
15 hours ago
RT @ECRIN_ERIC: ECRIN Director General, Jacques Demotes, discusses strengthening clinical research capacity including the need for national…See the post
5 days ago